| |
| |
|
| Insider
Information: |
Welch Daniel G |
| Relationship: |
|
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
681,552 |
|
|
Indirect Shares
|
123,508 |
|
|
| Direct
Value |
$7,743,872 |
|
|
|
Indirect Value
|
$4,223,974 |
|
|
| Total
Shares |
805,060 |
|
|
| Total
Value |
$11,967,846 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Chairman, CEO and Pres... |
2014-09-29 |
0 |
2004-08-12 |
0 |
Premium* |
|
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2023-12-14 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
Director |
2015-05-07 |
0 |
2014-05-27 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2023-06-07 |
21,605 |
2016-06-09 |
0 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
Director |
2018-05-15 |
0 |
2018-03-13 |
0 |
Premium* |
|
|
Structure Therapeutics Inc. |
GPCR |
Director |
2023-02-07 |
0 |
2023-02-07 |
123,508 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
|
2024-05-24 |
659,947 |
2024-05-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
127 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,044 |
8,297 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-01 |
4 |
OE |
$56.77 |
$444,529 |
D/D |
7,140 |
8,889 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-15 |
4 |
OE |
$38.82 |
$79,076 |
D/D |
2,037 |
9,256 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2013-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
9,619 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,503 |
9,649 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,750 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-02 |
4 |
OE |
$64.38 |
$1,140,601 |
D/D |
8,521 |
10,066 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-08-28 |
4 |
OE |
$135.63 |
$245,762 |
D/D |
1,812 |
10,109 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-08-28 |
4 |
AS |
$209.08 |
$336,619 |
I/I |
(1,610) |
10,725 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-04-03 |
4 |
AS |
$200.45 |
$2,162,296 |
I/I |
(10,725) |
12,335 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-02 |
4 |
AS |
$200.07 |
$1,167,408 |
I/I |
(5,835) |
12,335 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-14 |
4 |
AS |
$200.00 |
$108,800 |
D/D |
(544) |
12,977 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
13,119 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-14 |
4 |
OE |
$38.82 |
$18,245 |
D/D |
470 |
13,447 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,145 |
14,445 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2015-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
16,819 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2022-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
17,745 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-01 |
4 |
AS |
$200.06 |
$978,293 |
I/I |
(4,890) |
18,170 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,860 |
21,605 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-09-29 |
4 |
D |
$74.00 |
$5,268,948 |
D/D |
(71,202) |
23,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-13 |
4 |
OE |
$38.82 |
$593,370 |
D/D |
15,018 |
23,036 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-15 |
4 |
AS |
$200.05 |
$249,262 |
I/I |
(1,246) |
23,060 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-14 |
4 |
AS |
$200.00 |
$57,600 |
I/I |
(288) |
24,306 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-03-13 |
4 |
AS |
$200.20 |
$1,841,487 |
I/I |
(9,191) |
24,594 |
0 |
% |
|
| ITMN |
InterMune Inc |
President and CEO |
• • – |
2004-08-12 |
4 |
B |
$10.00 |
$250,000 |
D/D |
25,000 |
25,000 |
2.81 |
- |
|
127 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
